関連する実験動画
Updated: Feb 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
重度の肥満で食事と健康行動を改善するための第一歩として,多学科およびグループベースの介入です
Supreet Saluja1,2, Gabrielle Maston Suthern2, Sophia Kwan1,2
1Charles Perkins Centre Nepean, The University of Sydney, Kingwood, Australia.
Nutrition and health
|February 16, 2026
まとめ
この研究では,8週間の多学科グループ介入により,重度の肥満患者の健康行動と体重の改善が示されました. ベイ・ウェル・プログラムは,ボディ・マス・インデックス (BMI) を低下させ,気分を向上させ,その有効性を実証した.
科学分野:
- 肥満医学 肥満医学とは
- 行動科学は,行動科学である.
- 公衆衛生は公衆衛生である.
背景:
- 深刻な肥満の世界的な増加は,健康と医療システムに重大な課題をもたらします.
- 多分野,グループベースの介入は,健康行動と体重管理の改善に有望であることが示されています.
- 重度の肥満に対するこれらの介入の有効性に関する研究は限られている.
研究 の 目的:
- 8週間の"Be Well"グループベースの多分野介入の有効性を評価するために.
- 重度の肥満患者の食事行動,ボディマス指数 (BMI),および気分における初期変化を評価する.
- オーストラリアのニュー・サウス・ウェールズ州にある公的資金による病院ベースの肥満サービスでのアウトカムを調査するために.
主な方法:
- 深刻な肥満の127人が"Be Well"の介入に登録しました.
- 最初のセッションには98人が参加し,77人が8週間のプログラムを完了しました.
- 介入前と後の食事摂取量,BMI,および気分 (DASS-21スコア) の評価された変化.
主要な成果:
- BMI,任意の食事摂取量,およびうつ病およびストレススコアの有意な低下が観察されました.
- 参加者は,孤立感が減り,体重を超えて健康に対する理解が向上したと報告しました.
- この介入は,主要な健康指標に最初から良い影響を及ぼしました.
結論:
- グループベースの多学科的介入は,第三医療における重度の肥満の初期治療に有効です.
- このようなプログラムへの関与の障壁と促進要因を特定するために,さらなる研究が必要である.
- "Be Well"の介入は,重度の肥満管理の基本的要素として有望であることを示しています.
関連する概念動画
Binge Eating Disorders
528
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
528
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care
309
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
Chronic Pancreatitis II: Collaborative Care
388
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
388
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
301
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301

